Zdrowie i gospodarka · 11/05/2018

FDA Clears Path for Sodium Iodide I-123 Oral Solution Approval

The Food and Drug Administration (FDA) has determined that the oral solution of Sodium Iodide I-123, containing 2 millicuries per milliliter, was not withdrawn from sale due to safety or effectiveness concerns. This decision enables the FDA to approve abbreviated new drug applications (ANDAs) for this product if all applicable regulations are met.